NYSE:NVO (Novo Nordisk)
About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.
Novo Nordisk (NYSE: NVO) Latest News
Investing Articles
2 beaten-down shares to consider for a Stocks and Shares ISA in 2025
Investing Articles
Best US stocks to consider buying in December
Investing Articles
1 top growth stock on my Christmas buy list!
Investing Articles
2 Trump-hit stocks that look like golden opportunities for my Stocks and Shares ISA
Investing Articles
With these 3 growth stocks, I’m hoping to build generational wealth
Investing Articles
I think one of this year’s stock market favourites is due a breather. Here’s why
Growth Shares
I’ve bought these 3 magnificent growth stocks for my ISA to build generational wealth
Retirement Articles
I just put £4k into my SIPP. Here’s where I’m going to invest it
Growth Shares
Sell in May? I bought these 3 magnificent growth stocks last month!
Top Stocks
8 stocks that Fools have been buying!
Investing Articles
9 stocks that Fools have been buying!